Summary
Forty-eight dogs with spontaneously occurring osteogenic sarcoma (OS) were treated by amputation. Six dogs died soon after surgery, 34 dogs died or were euthanized 1–11 (median 4) months after, and eight dogs (17%) are alive 11–47 (median 21) months after amputation. Thirty-one dogs did not receive any therapy after amputation. Seventeen dogs received postamputation adjuvant immunotherapy consisting of intradermal bacillus Calmette-Guerin and an autologous tumor homogenate preparation administered every other week for 12 weeks. Twelve of these dogs were included in a prospectively randomized therapeutic trial in which a control group of 11 dogs received no therapy after amputation. Neither disease-free interval nor survival was prolonged by the immunotherapy protocol. Nevertheless, the current study demonstrates the feasibility of studying naturally occurring canine OS as a clinical and therapeutic model for OS in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bech-Nielsen, S., Brodey, R. S., Fidler, I. J., Abt, D. A., Reif, J. S.: The effect of BCG on in vitro immune reactivity and clinical course in dogs treated surgically for osteosarcoma. Eur. J. Cancer 13, 33 (1977)
Brodey, R. S., Abt, D. A.: Results of surgical treatment in 65 dogs with osteosarcoma. JAVMA 168, 1032 (1976)
Carter, S. K., Friedman, M.: Osteogenic sarcoma treatment overview and some comments on interpretation of clinical trial data. Cancer Treat. Rep. 62, 199 (1978)
Cortes, E. P., Holland, J. F., Glidewell, O.: Amputation and adriamycin in primary osteosarcoma: A 5-year report. Cancer Treat. Rep. 62, 271 (1978)
DeVita, V. T., Jr.: Adjuvant therapy — an overview. In: Adjuvant therapy of cancer. Salmon, S. E., Jones, S. E. (eds.), p. 613. Amsterdam: Elsevier/North-Holland Biomedical Press (1977)
Eilber, F. R., Townsend, C., Morton, D. L.: Osteosarcoma. Results of treatment employing adjuvant immunotherapy. Clin. Orthop. 3, 94 (1975)
Eilber, F. R., Grant, T., Morton, D. L.: Adjuvant therapy for osteosarcoma: Preoperative and postoperative treatment. Cancer Treat. Rep. 62, 213 (1978)
Fefer, A.: Adoptive tumor immunotherapy in mice as an adjunct to whole-body X-irradiation and chemotherapy. A review. Isr. J. Med. Sci. 9, 350 (1973)
Fidler, I. J., Brodey, R. S., Bech-Nielsen, S.: In vitro immune stimulation-inhibition to spontaneous canine tumors of various histologic types. J. Immunol. 112, 1051 (1974)
Frei, E., III, Jaffe, N., Skipper, H. E., Gero, M. G.: Adjuvant chemotherapy of osteogenic sarcoma: Progress and perspectives. In: Adjuvant therapy of cancer. Salmon, S. E., Jones, S. E. (eds.), p. 49. Amsterdam: Elsevier/North-Holland Biomedical Press 1977
Henness, A. M., Theilen, G. H., Park, R. D., Buhles, W. C.: Combination therapy for canine osteosarcoma. JAVMA 170, 1076 (1977)
Karnovsky, M. J.: A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J. Cell Biol. 27, 137A (1965)
Liu, S.-K., Dorfman, H. D., Hurvitz, A. I., Patnaik, A. K.: Primary and secondary bone tumours in the dog. J. Small Anim. Pract. 18, 313 (1977)
Luft, J. H.: Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9, 409 (1961)
Madewell, B. R., Leighton, R. L., Theilen, G. H.: Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma. Eur. J. Cancer 14, 287 (1978)
Millonig, G.: A modified procedure for lead staining of thin sections. J. Biophys. Biochem. Cytol. 11, 736 (1961)
Morton, D. L., Malmgren, R. A., Hall, W. T., Schidlovsky, G.: Immunologic and virus studies with human sarcomas. Surgery 66, 152 (1969)
Muggia, F. M., Louie, A. C.: Five years of adjuvant treatment of osteosarcoma: More questions than answers. Cancer Treat. Rep. 62, 301 (1978)
Nielsen, S. W.: Comparative pathology of bone tumors in animals, with particular emphasis on the dog. Recent Results Cancer Res. 54, 3 (1976)
Owen, L. N., Bostock, D. E.: Effects of intravenous BCG in normal dogs and in dogs with spontaneous osteosarcoma. Eur. J. Cancer 10, 775 (1974)
Owen, L. N., Bostock, D. E., Lavelle, R. B.: Studies on therapy of osteosarcoma in dogs using BCG vaccine. J. Am. Vet. Radiol. Soc. 18, 27 (1977)
Simon, R.: Clinical prognostic factors in osteosarcoma. Cancer Treat. Rep. 62, 193 (1978)
Sinkovics, J. G., Williams, D. E., Campos, L. T., Kay, H. D., Romero, J. J.: Intensification of immune reactions of patients to cultured sarcoma cells: Attempts at monitored immunotherapy. Semin. Oncol. 1, 351 (1974)
Sober, H. A. (Ed.): Handbook of biochemistry, 2nd ed. Cleveland, Ohio: Chemical Rubber Co. 1970
Sutow, W. W., Gehan, E. A., Dyment, P. G., Vietti, T., Miale, T.: Multidrug adjuvant chemotherapy for osteosarcoma: Interim report of the Southwest Oncology Group studies. Cancer Treat. Rep. 62, 265 (1978)
Taylor, N., Shifrine, M., Wolf, H. G., Trommershausen-Smith, A.: Canine osteosarcoma karyotypes from an original tumor, its metastasis, and tumor cells in tissue culture. Transplant. Proc. 7, 485 (1975)
Thurman, G. B., Mays, C. W., Taylor, G. N., Keane, A. T., Sissons, H. A.: Skeletal location of radiation-induced and naturally occurring osteosarcomas in man and dog. Cancer Res. 33, 1604 (1973)
Tsoi, M. S., Weiden, P. L., Storb, R.: Lymphocyte reactivity to autochthonous tumor cells in dogs with spontaneous malignancies. Cell. Immunol. 13, 431 (1974)
Tsoi, M. S., Weiden, P. L., Storb, R.: Immunologic reactivity to soluble autochthonous tumor extracts in dogs with spontaneous malignancies. J. Immunol. 116, 1134 (1976)
Yarkoni, E., Zbar, B., Rapp, H. J.: Resistance to tumor growth in guinea pigs immunized with lyophilized tumor cells. Cancer Immunol. Immunother. 2, 201 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weiden, P.L., Storb, R., Tsoi, MS. et al. Canine osteosarcoma: Results of amputation with and without adjuvant immunotherapy. Cancer Immunol Immunother 5, 181–186 (1978). https://doi.org/10.1007/BF00199626
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199626